daunorubicin has been researched along with HIV Coinfection in 18 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (66.67) | 18.2507 |
2000's | 4 (22.22) | 29.6817 |
2010's | 2 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bendle, M; Bower, M; Papanastasopoulos, P; Pealing, J | 1 |
Burns, A; Davidson, RN; Gow, NJ; Thomas, MG; Ticehurst, R | 1 |
Oksenhendler, E | 1 |
Ghosh, K; Gupta, M; Jijina, F; Madkaikar, M; Mohanty, D; Rajpurkar, M | 1 |
Forteza, AM; Koch, S; Ortiz, G; Rabinstein, AA; Romano, JG | 1 |
Kane, D; Keating, S; McCann, S; Mulcahy, F | 1 |
White, RM | 1 |
Goebel, FD; Jablonowski, H | 1 |
Bennett, C; Hjortsberg, C; Lidbrink, E; Persson, U | 1 |
Pozo, F; Rivero, A; Serrano, R; Tenorio, A; Torre-Cisneros, J; Vidal, E | 1 |
Wernz, JC | 1 |
Link, D | 1 |
2 review(s) available for daunorubicin and HIV Coinfection
Article | Year |
---|---|
HIV-associated multicentric Castleman disease.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Asparaginase; Castleman Disease; Clinical Trials as Topic; Cytarabine; Daunorubicin; Etoposide; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV Infections; Humans; Lymph Nodes; Rituximab; Thioguanine; Valganciclovir; Virus Replication | 2009 |
The management of acute myeloid leukaemia (AML) in human immunodeficiency virus (HIV) infection: a case report and review.
Topics: Adult; Anti-HIV Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Cytarabine; Daunorubicin; Drug Therapy, Combination; HIV Infections; Humans; Leukemia, Myeloid, Acute; Male; Thioguanine; Zidovudine | 1997 |
2 trial(s) available for daunorubicin and HIV Coinfection
Article | Year |
---|---|
Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, Portugal.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Antiviral Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Hepatitis C, Chronic; Herpesvirus 8, Human; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; Sarcoma, Kaposi | 1999 |
Patterns of lymphotropic herpesvirus viraemia in HIV-infected patients with Kaposi's sarcoma treated with highly active antiretroviral therapy and liposomal daunorubicin.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Daunorubicin; Didanosine; Drug Therapy, Combination; Herpesvirus 8, Human; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; Sarcoma, Kaposi; Stavudine; Viremia | 2000 |
14 other study(ies) available for daunorubicin and HIV Coinfection
Article | Year |
---|---|
Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi's sarcoma (KS).
Topics: Adolescent; Adult; Aged; Anthracyclines; Anti-HIV Agents; Antibiotics, Antineoplastic; Daunorubicin; Follow-Up Studies; HIV Infections; Humans; Liposomes; Male; Middle Aged; Neoplasms, Second Primary; Risk Factors; Sarcoma, Kaposi; Treatment Outcome; Viral Load; Young Adult | 2014 |
Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.
Topics: Anti-HIV Agents; Antiprotozoal Agents; Coinfection; Daunorubicin; Drug Resistance; HIV Infections; HIV-1; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Treatment Failure | 2015 |
Tuberculosis and immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Asparaginase; Comorbidity; Daunorubicin; HIV Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; India; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Rifampin; Thrombocytopenia; Tuberculosis; Vincristine | 2002 |
Mechanisms of ischemic stroke in HIV-infected patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Ischemia; Cardiolipins; CD4 Lymphocyte Count; Cerebral Hemorrhage; Child; Child, Preschool; Cocaine-Related Disorders; Comorbidity; Cytarabine; Daunorubicin; Female; HIV Infections; Humans; Incidence; Intracranial Arteriosclerosis; Intracranial Embolism; Male; Middle Aged; Protein S Deficiency; Retrospective Studies; Stroke; Thioguanine; Thrombophilia; Vasculitis | 2007 |
DaunoXome data presented at international cancer meeting.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daunorubicin; Doxorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Lung Neoplasms; Sarcoma, Kaposi; Vinblastine | 1996 |
[New data: daunoxome against Kaposi sarcoma. Fifth European Conference on clinical aspects and treatment of HIV infection].
Topics: Antibiotics, Antineoplastic; Daunorubicin; HIV Infections; Humans; Sarcoma, Kaposi | 1996 |
Mislabeling of drug for Kaposi's sarcoma rectified.
Topics: Clinical Trials, Phase III as Topic; Daunorubicin; Dose-Response Relationship, Drug; Drug Labeling; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration | 1997 |
Liposomal daunorubicin is not recommended in patients with less than advanced HIV-related Kaposi's sarcoma.
Topics: AIDS-Related Opportunistic Infections; Antibiotics, Antineoplastic; Clinical Trials as Topic; Cross-Over Studies; Daunorubicin; Drug Carriers; HIV Infections; Humans; Immunocompromised Host; Liposomes; Sarcoma, Kaposi | 1997 |
Cost-effectiveness analysis of pegylated-liposomal doxorubicin and liposomal daunorubicin treatments in patients with Kaposi's sarcoma.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cost-Benefit Analysis; Daunorubicin; Doxorubicin; Drug Carriers; Drug Costs; HIV Infections; Humans; Liposomes; Polyethylene Glycols; Randomized Controlled Trials as Topic; Retrospective Studies; Sarcoma, Kaposi; Sweden | 1999 |
Liposomal drug targeting in the treatment of Kaposi's sarcoma.
Topics: Adult; Antibiotics, Antineoplastic; Daunorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Male; Middle Aged; Sarcoma, Kaposi; Treatment Outcome | 1996 |
DaunoXome approved.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Carriers; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi | 1996 |
Kaposi's sarcoma: DaunoXome approved.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Doxorubicin; Drug Approval; Drug Carriers; HIV Infections; Humans; Liposomes; Sarcoma, Kaposi; United States; United States Food and Drug Administration | 1996 |
FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
Topics: Antineoplastic Agents; Daunorubicin; Drug Approval; Drug Carriers; HIV Infections; Humans; Liposomes; Quality of Life; Sarcoma, Kaposi; Treatment Outcome; United States; United States Food and Drug Administration | 1996 |
New York ADAP to cover new AIDS drugs plus viral load testing.
Topics: Acquired Immunodeficiency Syndrome; Antibiotics, Antineoplastic; Antiviral Agents; Cytomegalovirus Infections; Daunorubicin; Drug Costs; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Insurance, Pharmaceutical Services; Lobbying; Nevirapine; New York; Pyridines; Sarcoma, Kaposi | 1996 |